Kadera and colleagues aimed to perform a detailed survival analysis of their institution’s experience with patients with locally advanced/borderline resectable pancreatic ductal adenocarcinoma who were downstaged and underwent surgical resection and (2) identify prognostic biomarkers that may help guide a decision for the use of adjuvant therapy in this patient subgroup. L. Andrew DiFronzo, MD, provided an invited commentary.
Findings from this retrospective review show the importance of removing the less radioactive nodes in patients with cutaneous melanoma.
This study of medical records in a prospectively maintained database identifies factors associated with survival in patients with periampullary adenocarcinomas and compares survival between those having intestinal-type or pancreaticobiliary-type cancers originating from the duodenum, ampulla, or distal common bile duct with those having pancreatic ductal adenocarcinoma.
This multicenter study of patients after liver resection for hilar cholangiocarcinoma evaluates whether the number of positive lymph nodes or the lymph node ratio was most accurate for staging.
This prospective cohort study examines the genetic and epigenetic events associated with follicular thyroid hyperplasia.
This case series uses review of medical records to report on potential immunohistochemical prognostic molecular markers to determine their prognostic and therapeutic utility for patients with vascular leiomyosarcomas.
This laboratory study examines the MC-2 peptide’s association with reduced liver injury following rescuscitated hemorrhagic shock in rats.
A 64-year-old man from the Philippines presented with 5 months of progressive fatigue, worsening jaundice, and a 13-kg weight loss and no fever, chills, or abdominal pain. What is your diagnosis?